Benefits Outcome-first
A trial evaluating 60 patients with MCI or probable AD discovered that treatment with 40 IU of the long-acting insulin analog, insulin detemir, improved cognition [162]
doi:10.1016/j.advnut.2024.100252 Zietzer A, Dusing P, Reese L, Nickenig G, Jansen F
Combining both: Alternate ginger and peppermint
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries
The IDEA trial (Messier 2013 JAMA) earlier showed that 10 percent weight loss produces significant knee pain improvement